Ahad Rahim was recently featured in a blog post by the UCL Translational Research Office regarding his work in the development of novel therapies and rare diseases. At the end of 2019, he received an MRC DPFS grant of £654,904 to develop gene therapy for infantile neuroaxonal dystrophy (INAD).
The full blog post can be viewed here: The Development of Gene Therapy for Infantile Neuroaxonal Dystrophy